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ABSTRACT
The vertebrate 2-5A system is part of the innate im-
mune system and central to cellular antiviral
defense. Upon activation by viral double-stranded
RNA, 50-triphosphorylated, 20–50-linked oligoadeny-
late polyribonucleotides (2-5As) are synthesized by
one of several 20–50-oligoadenylate synthetases.
These unusual oligonucleotides activate RNase L,
an unspecific endoribonuclease that mediates viral
and cellular RNA breakdown. Subsequently, the
2-5As are removed by a 20-phosphodiesterase
(20-PDE), an enzyme that apart from breaking 20–50
bonds also degrades regular, 30–50-linked oligoa-
denylates. Interestingly, 20-PDE shares both func-
tionally and structurally characteristics with the
CCR4-type exonuclease–endonuclease–phosphat-
ase family of deadenylases. Here we show that
20-PDE locates to the mitochondrial matrix
of human cells, and comprise an active 30–50
exoribonuclease exhibiting a preference for oligo-
adenosine RNA like canonical cytoplasmic dead-
enylases. Furthermore, we document a marked
negative association between 20-PDE and mitochon-
drial mRNA levels following siRNA-directed
knockdown and plasmid-mediated overexpression,
respectively. The results indicate that 20-PDE, apart
from playing a role in the cellular immune system,
may also function in mitochondrial RNA turnover.
INTRODUCTION
Interferons (IFNs) are vertebrate-speciﬁc cytokines with
key roles in innate immunity (1,2). They induce a range
of biological responses, of which their antiviral, antitumor
and immuno-modulatory effects are of major medical
signiﬁcance (3,4). Upon viral infection, cells begin
synthesizing and secreting the IFNs, which then interact
with speciﬁc receptors at the cell surface to activate an
intracellular signal cascade, eventually leading to the
changes in gene expression that dictate the biological
outcome.
The 2-5A system forms a major part of the cellular
antiviral defense in which IFNs initially induce
expression of a set of double-stranded RNA-dependent
20–50-oligoadenlyate synthetases (dsRNA-dependent
20–50-OASs). Upon activation by viral dsRNA, these
enzymes begin synthesizing a set of unusual
50-triphosphorylated, 20–50-linked oligoadenylate
polyribonucleotides (2-5As) from ATP with the general
structure, pppA(20p5 0A)n (5). Accumulation of 2-5As
then causes activation of RNase L, an otherwise latent
endoribonuclease, leading to the degradation of viral
RNA. However, RNase L is only moderately speciﬁc
towards viral RNA and will degrade cellular RNA if not
deactivated (6,7). Consequently, the intracellular 2-5A
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contrast to canonical exonucleases, degrades 20–50-linked
RNA (8,9).
The removal of 2-5As is thought to initially involve
dephosphorylation by a 50-phosphatase, as activation of
the pathway by viral infection and IFN stimulation in
mice and in cell cultures have been shown to lead to
accumulation of 50-dephosphorylated 2-5As (2-5A core
molecules) rather than their 50-triphosphorylated counter-
parts (10,11). Although less active in stimulating RNase L
(12), the dephosphorylated 2-5A core molecules still have
signiﬁcant antiviral and anti-growth properties and need
to be fully removed to shut down the response (13,14).
Both phosphorylated and dephosphorylated 2-5As can
be degraded by a 20–50-speciﬁc exoribonuclease known as
20-phosphodiesterase [20-PDE (also named phospho-
diesterase 12 (PDE12))], which is thus a key regulator of
the 2-5A system (9).
20-PDE is also able to degrade 30–50-linked
oligoadenylate RNAs in vitro (9,15,16), and has therefore
been classiﬁed as a putative RNA deadenylase (17).
Deadenylases are a diverse group of enzymes responsible
for removing the poly(A) tail during early mRNA
turnover in the eukaryotic cytoplasm. Most deadenylases
are 30–50 exonucleases that produce AMP by hydrolyzing
the phosphodiester bonds of RNA in a divalent metal
ion-dependent fashion (17). The process represents the
ﬁrst and rate-limiting step during mRNA turnover and
is therefore highly regulated (17,18). All deadenylases
characterized to date belong to either the DEDD or the
exonuclease–endonuclease–phosphatase (EEP) superfam-
ily (17). In DEDD-type nucleases, the active site consists
of three aspartate residues and one glutamate that coord-
inate two essential divalent metal ions (19–21). In humans,
members of this group include the POP2, CAF1Z, PARN
and PAN2 proteins. The EEP-type nucleases, to which
20-PDE belongs, also depend on divalent metal ions and
contain an active site composed of aspartate and histidine
residues (22,23). This group comprises enzymes active on
both DNA and RNA, and includes the CCR4, Nocturnin
and ANGEL proteins.
Here we show that human 20-PDE, unlike other com-
ponents constituting the 2–5A system (24–29), is located in
the mitochondrial matrix compartment, and comprises
a general 30–50 exoribonuclease exhibiting a preference
for oligo-adenosine RNA like canonical cytoplasmic
deadenylases (21,22,30–33). Furthermore, we document
the presence of a marked negative association between
20-PDE and mitochondrial mRNA levels, following
siRNA-directed knockdown and plasmid-mediated
overexpression, respectively. Collectively, the results
suggest that 20-PDE may play a dual role in cells, being
involved in mitochondrial RNA turnover as well as the
2-5A system.
MATERIALS AND METHODS
20-PDE expression constructs
The cDNA clone DKFZp667B1218 (GenBank accession
no. BX647169) was used as template for PCR
ampliﬁcation of the 20-PDE fragments, inserted into
either pcDNA3 (Invitrogen) or pTriEx-3 Neo (Novagen).
Cell culturing and transfection
HeLa, HEK293 or COS-7 cells were grown in DMEM
(Gibco BRL/Life Technology) containing 10% FBS
and 1% Penicillin/Streptomycin (Gibco BRL/Life
Technology). HEK293 and HeLa cells were transfected
using the PolyFect Transfection Reagent (Qiagen), and
COS-7 cells were transfected using Lipofectamine
(Invitrogen). Cells were lysed with 1% NP40, 0.5M
CH3COOK containing 2  Complete protease inhibitor
cocktail (Roche). The cell lysates were centrifuged at
20000g for 3min and the supernatants recovered as
protein extracts. Protein concentrations were estimated
using the BCA Protein Assay Kit (Pierce).
Escherichia coli expression and protein puriﬁcation
Escherichia coli BL21 (DE3) cells were transformed with
20-PDE615-His, 20-PDEmTP600-His and OAS1-p42 in
pTriEx-3 Neo, and as a control also with empty vector
pTriEx-3 Neo. Then the bacteria were grown in LB
medium containing 50mg/ml ampicillin before induction
at OD600=0.8 with 1mM IPTG for 10h at 25 C.
Bacteria were pelleted at 10000g for 20min and resus-
pended in 300mM KCl, 15% glycerol, 5mM MgCl2,
5mM b-mercaptoethanol, 1mM PMSF, 1  protease
inhibitor cocktail and 50mM Tris–HCl, pH 7.5. This
suspension was sonicated and lysed by high-pressure
homogenization at 15000–20000psi. Cell debris were
spun down at 30000g for 1h and discarded. For puriﬁca-
tion, the supernatant was ﬁltered through a 0.45-mm ﬁlter
and applied to a Ni-NTA column (QIAGEN)
pre-equilibrated in 300mM KCl, 20mM imidazole,
5mM b-mercaptoethanol, 1mM PMSF, 1  protease in-
hibitor cocktail and 50mM Tris–HCl, pH 7.5. Proteins
were eluted by a step-gradient using 300mM imidazole.
The Ni-NTA eluate was diluted and applied to a MonoQ
HR 16/10 column (GE Healthcare) pre-equlibrated in
50mM KCl, 5mM b-mercaptoethanol and 50mM
Tris–HCl, pH 7.5, and eluted with a linear KCl gradient
of 0.2%/ml going from 50 to 500mM. Fractions were
pooled and concentrated on a 5-kDa MWCO Vivaspin
ﬁlter (Sartorius), and stored in 50% glycerol.
SDS–PAGE and immunoblotting
Proteins were denatured at 95 C for 5min and applied to
10% SDS–PAGE. Gels were stained in Coomassie
Brilliant Blue R-250 (Pierce). For immunoblotting,
proteins were electro-blotted onto Immobilon-P PVDF
membranes (Millipore). Membranes were blocked
in 5% skimmed milk powder in PBS-T (PBS with 0.05%
Tween-20), washed in PBS-T and incubated with anti-His
antibodies (Rockland or GenScript Corporation).
Membranes were washed in PBS-T and incubated with
either of two HRP-conjugated IgGs, goat anti-rabbit
antibody (DakoCytomation) or goat anti-mouse
antibody (GE Healthcare). Proteins were detected with
the ECL reagent (Amersham ECL Plus
TM,G E
Healthcare).
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The following online bioinformatic tools were used:
WoLF PSORT (http://wolfpsort.org/), pTARGET
(http://bioapps.rit.albany.edu/pTARGET/), MitoProt II
(http://mips.helmholtz-muenchen.de/cgi-bin/proj/medgen
/mitoﬁlter), PSORT (http://psort.ims.u-tokyo.ac.jp/form
.html), GPMAW (http://www.gpmaw.com/Downloads/
downloads.html), Phobius (http://phobius.sbc.su.se/),
TopPred (http://www.cbib.u-bordeaux2.fr/pise/toppred
.html) and MultiAlin (http://bioinfo.genotoul.fr/
multalin/multalin.html).
Immunocytochemistry
HeLa and HEK293 cells were seeded on coverslips, trans-
fected with PolyFect and incubated for 36h. The growth
media was supplemented with 100nM Mitotracker (Red
CMXRos, Invitrogen) for 30min. Cells were ﬁxed with
4% PFA, washed in PBS, permeabilized with 0.2%
Triton-X 100, washed again and ﬁnally blocked with
0.1% Tween-20 in PBS. Cells were then incubated with
an anti-His antibody (Rockland or Genscript), washed
and incubated with a FITC-conjugated secondary
antibody (Sigma). Cells were ﬁnally washed, air-dried
and the coverslips mounted using Vectashield (Vector
Laboratories). Images were acquired with a Zeiss
LSM510 MetaConfocal microscope. The brightness and
contrast of the resulting images were adjusted using the
LSM Image Software.
Synthesis of 20–50 oligoadenylate tetramer core, ApApApA
In 200ml, 17mg/ml of a highly active 20–50-OAS1 was
incubated with 2mM ATP in 4mM Mg(OAc)2, 0.2mM
DTT, 40mM EDTA, 0.2mg/ml Poly(I)-Poly(C), 0.1mg/ml
BSA, 2% glycerol and 4mM Tris–HCl, pH 7.8 for 3h at
37 C. The ATP concentration was increased from 2 to
10mM by addition of 1mM ATP every 10min. The
sample was heat-inactivated at 85 C for 15min, ﬁltered
(0.45mm) and then applied 100U/ml alkaline phosphatase
(Roche Applied Science) overnight at 37 C. The sample
was then divided into 10ml aliquots and each aliquot
loaded onto a MonoQ HR 16/10 column pre-equilibrated
in 20mM Tris–HCl, pH 7.5, and eluted with 1 M NaCl
using a step-wise linear gradient of 0–10% over
3.6-column volumes and 10–30% over 24-column
volumes. The tetramer oligoadenylate core fractions
were then pooled, diluted in 20mM Tris–HCl, pH 7.5,
again applied to the MonoQ HR 16/10 column and
ﬁnally eluted with a step-gradient to 0.5 M NaCl. The
identity of the tetramer core was determined by MS and
a concentration estimate was obtained by MonoQ
Sepharose using ATP as an internal control.
Degradation assay and determination of Km and Vmax
For the 20–50-linked tetramer, ApApApA, reactions were
carried out with 1pmol/ml2 0-PDE and 0.5mM substrate
in 5mM MgCl2, 1mM DTT, 1mg/ml BSA, 1x protease
inhibitor cocktail and 20mM Hepes, pH 7.0 for 1h at
37 C. The samples were diluted in 20mM Tris–HCl, pH
7.5 and ﬁltered on AcroPrep
TM 10K Filter Plates
(Pall Corporation). The ﬁltrates were applied to a
MonoQ HR 5/5 column (GE Healthcare) pre-equilibrated
in 20mM Tris–HCl, pH 7.5, and eluted with 1 M NaCl
using a step-wise linear gradient of 0–12% and 12–16%
over 18-column volumes and 20-column volumes,
respectively. The percentage tetramer core conversion
was calculated by integrating the individual peaks.
The 20–50 oligoadenylate degradation assay was
repeated with the 30–50-linked tetramer substrates,
ApApApA and CpCpCpC (Dharmacon), using 1pmol/
ml2 0-PDE and varying substrate concentrations
(25mM–1.5mM). Reactions were incubated 20min at
37 C and processed as above by ﬁltration, MonoQ
Sepharose fractionation and peak integration. Km and
Vmax kinetic parameters were determined by non-linear
regression and Michaelis–Menten enzyme kinetics using
the GraphPad Prism Software.
For the 30-mer RNA- and DNA-degradation assay, the
RNA–Poly(A), the RNA Stemloop–Poly(A) and
the DNA–Poly(A) substrates were synthesized with a 50-
ﬂuorescein label whereas the RNA–Poly(C) substrate was
synthesized with a 50-TAMRA label (Invitrogen). All
substrates were gel-puriﬁed. In vitro reactions contained
a 100-fold excess of enzyme (1mM) over RNA (10nM)
and were carried out in 50mM KCl, 7.1mM MgCl2 and
10mM Tris–HCl, pH 8.0. Reactions were incubated at
30 C for up to 2h, quenched with RNA-loading buffer
(8M urea, 0.5% (w/v) bromophenol blue, 0.5% (w/v)
xylene cyanol FF, 20mM EDTA and 5mM Tris–HCl,
pH 8.0), separated by denaturing gel electrophoresis on
20% urea-acrylamide gels running at 15W and the
bands visualized with a Typhoon 9400 and Typhoon
Trio scanner (GE Healthcare). The RNA and DNA
ladders were constructed by limited alkaline hydrolysis
of the respective substrates in 50mM NaCO3, pH 8.9
for 10min at 96 C followed by neutralisation with
300mM Na(CH3COO), pH 4.5.
Differential cell processing
Cells were harvested in PBS using a cell scraper, pelleted at
1000g for 10min, resuspended in 220mM mannitol,
70mM sucrose, 1mM EDTA, 2mg/ml BSA, 2 
protease inhibitor cocktail, 0.5mM PMSF and 20mM
Hepes, pH 7.6, homogenized with a Dounce homogenizer,
and the cell debris pelleted at 1000g for 10min. Recovered
supernatants were centrifuged for 20min at 10000g, and
the pellet (mitochondria) and supernatant (cytosol and
microsomes) split up. Mitochondria were resuspended as
above but without BSA, and any remaining cell debris
pelleted at 1000g for 10min. The supernatants were
centrifuged, again for 20min at 10000g, and the resulting
mitochondrial pellets resuspended in urea buffer (6 M
urea and 50mM Tris–HCl, pH 8.0) for MS and
gel-fractionation, or 1x OFFGEL Solution (6.7 M urea,
2 M thiourea, 60mM DTT and 1.2% ampholytes, pH 3–
10) for off-gel fractionation, or BSA Buffer (3mg/ml fatty
acid-free BSA, 250mM sucrose, 80mM KCl, 5mM
MgCl2, 2mM KH2PO4, 5mM methionine and 10mM
MOPS–KOH, pH 7.2) for in vitro mitochondrial import.
The cytosol and microsomes were segregated by
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(cytosol) TCA-precipitated and resuspended in urea
buffer. Mitochondrial protein concentration was
estimated using the Bradford assay reagent (Pierce) and
the cytosolic protein concentration using the BCA
method.
35S-labeling and in vitro mitochondrial import
35S-labeled 20-PDE615-His was synthesized at 30 C for
1.5h using the TNT T7 Quick Coupled Transcription/
Translation system (Promega). Import reactions were
carried out in 1% ethanol, 0.45mg/ml mitochondria,
1.25ml
35S-labeled 20-PDE, 5mM ATP, pH 7.0 and
10mM sodium succinate, pH 7.5 in BSA buffer. The
membrane potential (c) was disrupted by substituting
ethanol with 80mM antimycin A, 10mM valinomycin
and 20mM oligomycin and leaving out sodium succinate.
Reactions were carried out at 30 C for different
time-points and stopped with 2mM valinomycin.
Non-imported protein was digested for 10min at 4 C
using 50mg/ml proteinase K followed by inhibition of
the protease with 2mM PMSF at 4 C for 10min.
Mitochondria were pelleted as above and washed by
resuspension in SEM Buffer (250mM sucrose, 1mM
EDTA, 2mM PMSF and 10mM MOPS–KOH, pH 7.2).
The pellets were ﬁnally dissolved in sample buffer contain-
ing 2mM PMSF and applied to SDS–PAGE. For the car-
bonate extraction experiment, mitochondria were exposed
to 0.1 M sodium carbonate (pH 11.5) for 30min on ice
after protein import. Samples were then ultracentrifuged
at 100000g for 30min at 4 C and the supernatants
(soluble and peripheral membrane proteins) exposed to
TCA-precipitation in 125pg/ml sodium deoxycholate.
Proteins were ﬁnally redissolved in PMSF-containing
sample buffer and allowed to solubilize by incubation
for 10min at RT. Ultracentrifuged pellets (integral
membrane proteins) were resuspended in sample buffer
containing PMSF. For the mitochondrial swelling experi-
ment, mitochondria were resuspended in SM Buffer
(250mM sucrose with 10mM MOPS–KOH, pH 7.2)
after protein import and treated with nine volumes
10mM MOPS–KOH, pH 7.2 for 15min on ice, or as a
control, kept intact by soaking in nine volumes SM Buffer.
Accessible proteins were removed by proteinase K treat-
ment or left untreated as control. The mitochondria/
mitoplasts were then pelleted by centrifugation, washed
in SEM Buffer and redissolved in sample buffer.
For autoradiography, samples were applied to
SDS–PAGE and the gel ﬁxed and dried. Proteins were
visualized by phosphorimaging using the Typhoon 9400
and Typhoon Trio scanner.
Tryptic digest of crude mitochondria
Mitochondrial proteins ( 1mg) dissolved in urea buffer
were reduced in 10mM DTT for 18h at 37 C, then
alkylated in 30mM iodoacetamide for 1h at room
temperature. The reaction was stopped by adding add-
itional DTT to 40mM. The proteins were diluted
10 times with 1mM CaCl2 in 10mM Tris–HCl, pH 8.0,
and digested using 5ng/ml trypsin for a period of 18h at
37 C. The pH of samples for MS analysis was adjusted to
approximately 2–3 with 0.1% TFA.
Off-gel fractionation and preparation for MS
Proteins were off-gel fractionated at 200V for 25h (5 kVh)
and 50mA (3100 OFFGEL fractionators, Agilent) into 12
fractions using immobilized pH gradient gel strips
covering the pH interval 3–10. The fractions were
digested with trypsin and the peptides puriﬁed by
Zip-Tips (0.2mlC 18 resin, Millipore). Peptides were
ﬁnally dried down by SpeedVac centrifugation and
redissolved in 0.1% TFA.
RP-HPLC and MS
Samples were analyzed using the UltiMate 3000 LC
system (Dionex) linked to a micrOTOF-Q ESI-Qq-TOF
mass spectrometer (Bruker Daltonics, Bremen). The
software Bruker Compass HyStar (Version 3.2-SR2,
Bruker Daltonics) was used to link the RP-HPLC and
the mass spectrometer controlling software packages.
The HPLC used a C18 RP-column (PepMap 100
nanocolumn, Dionex) to fractionate the peptides.
Peptides were applied to the column, the column washed
in 2% acetonitrile+0.1% formic acid and peptides eluted
with a linear gradient of 98% acetonitrile in 0.1% aqueous
formic acid. The gradient was run from 0% to 2%, from
2% to 42% and from 42% to 99% over, respectively, 20,
160 and 76ml with a ﬂowrate of 4ml/min. The peptides MS
and MS/MS spectra were recorded online by the mass
spectrometer.
MS sample ﬁles were processed, denoted and
deconvoluted using DataAnalysis (Version 4.0 SP1,
Bruker Daltonics, Germany). The peptide spectra were
exported to BioTools (Version 3.1, Bruker Daltonics,
Germany) and matched against the peptides resulting
from a virtual tryptic digest of 20-PDE. To estimate mito-
chondrial purity, MS/MS data were applied to the Mascot
search engine (Version 2.2, Matrix Science, United
Kingdom) and probed against the full repertoire of
human proteins contained in the Swiss-Prot protein
database. Purities were deduced based on the known
cellular localization of the detected proteins.
siRNA knockdown and plasmid-mediated overexpression
of 20-PDE in HeLa cells, for qRT-PCR
A pool of four siRNAs (target sequences: 50-GAAGAUU
GAAUUAGCGUGU-30,5 0-AGUACAAGGUGGAGC
GCAA-30,5 0-CGGCAUCUCUACACGAAGA-30 and
50-CAAACUCAGCCUCGAAUUU-30) (Dharmacon)
was employed to knockdown the 20-PDE gene expression
level (20-PDE ON-TARGET plus SMARTpool siRNA).
A negative control siRNA was targeting GFP (target
sequence: 50-GACGTAAACGGCCACAAGTC-30)
(Dharmacon). Plasmid-mediated protein overexpression
was done using the 20-PDE615-His construct cloned in
pcDNA3.
siRNA and plasmid transfections of HeLa cells were
carried out in 6-well plates using the DharmaFECT 1
(Dharmacon) or PolyFect (Qiagen) Transfection
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instructions. 72 hours (siRNA) and 36h (plasmid)
post-transfections, cells were harvested and the total
RNA isolated using the RNeasy Mini Kit (Qiagen).
Quantitative reverse transcriptase PCR analysis
First-strand cDNA was prepared using 1.5mg total RNA,
oligo(dT)18 primer and the MMLV Reverse Transcriptase
(Epicenter Biotechnologies) in a ﬁnal volume of 50ml. Each
quantitative reverse transcriptase (qRT)-PCR reaction
contained 1ml ﬁrst-strand cDNA and 200nM of both
forward and reverse primers in a ﬁnal volume of 20ml,
and was carried out using the Platinum SYBR Green
qPCR SuperMix UDG Kit supplemented with ROX
Reference Dye (Invitrogen). Gene-speciﬁc primer sets
were as follows: 20-PDE forward, 50-GTCATCAATGGC
AGCATTCCAGAG-30;2 0-PDEreverse, 50-CTATTTCCA
TTTTAAATCACATACAAGTGC-30; CoxI forward, 50-
ACCCTAGACCAAACCTACGCCAAA-30; CoxI
reverse, 50-TAGGCCGAGAAAGTGTTGTGGGAA-30;
CoxII forward, 50-ACAGATGCAATTCCCGGACGTC
TA-30; CoxII reverse, 50-GGCATGAAACTGTGGTTTG
CTCCA-30; CoxIII forward, 50-ACTTCCACTCCATAAC
GCTCCTCA-30; CoxIII reverse, 50-TGGCCTTGGTATG
TGCTTTCTCGT-30; CytB forward, 50-TCCTCCCGTGA
GGCCAAATATCAT-30; CytB reverse, 50-AAAGAATC
GTGTGAGGGTGGGACT-30; ND4 forward, 50-ACAA
GCTCCATCTGCCTACGACAA-30; ND4 reverse, 50-TT
ATGAGAATGACTGCGCCGGTGA-30; ND6 forward,
50-AGGATTGGTGCTGTGGGTGAAAGA-30; ND6
reverse, 50-ATAGGATCCTCCCGAATCAACCCT-30;
RPL13A forward, 50-CCTGGAGGAGAAGAGGAAA
GAGA-30; RPL13A reverse, 50-TTGAGGACCTCTGTG
TATTTGTCAA-30. The results were obtained with the
Mx3005PSystem(Stratagene),andthePCRthermocycling
conditions were: 95 C for 10min, and 40 cycles of 95 C for
10s, 58 C for 20 s and 72 C for 20 s. Band sizes of PCR
products were veriﬁed by standard agarose gel electrophor-
esis, and the melting-curve analysis of all PCR products
displayed single melting peaks. Signal levels were
normalized to the ROX reference dye for correction of
errors due to differences in plastic-ware transparency and
reﬂectivity, or aliquoting errors. The outcome Ct values
were converted to quantities using the comparative Ct
method, incorporating the efﬁciencies of the reaction with
each primer set, which were determined as described previ-
ously (34). Relative gene expression levels were normalized
to values of the RPL13A gene, encoding a stably expressed
ribosomal protein (35).
RESULTS
20-PDE contains an N-terminal mitochondrial signal
peptide
Initially, full-length 20-PDE (609 amino acids) was cloned
from human cDNA into the eukaryotic expression vector
pcDNA3, to encode a 615 amino acids (68kDa) fusion
protein containing a C-terminal 6t His-tag (20-PDE615-
His) (Figure 1A). After transient transfections, two
(HEK293 cells, Figure 1B) or three (HeLa cells,
Figure 1C) speciﬁc bands were observed corresponding
to the full-length protein and either degraded or
post-translationally processed products. No degradation
was observed upon expression of a control construct con-
taining the 20–50-oligoadenylate synthetase, OAS1-p42,
suggesting that protein processing could be involved in
generating the multiple bands.
To further analyze the likelihood of protein processing
and possibly a sub-cellular localization other than the
cytosol, the algorithms WoLF PSORT and pTARGET
were used to predict the cellular localization of 20-PDE
based on sequence (36). Both clearly identiﬁed a mitochon-
drial signal peptide, also referred to as a matrix-targeting
peptide, mTP, in the N-terminus of 20-PDE (37,38).
Figure 1. Constructs and expression of 20-PDE in human cells. (A) The 20-PDE constructs. 20-PDE615-His encodes the full-length protein added a
C-terminal His-tag, whereas 20-PDEmTP600-His makes up an N-terminal truncated form of the 20-PDE615-His devoid of the ﬁrst 16 residues
(vertical arrow in top row) and containing an artiﬁcial initiator methionine (M). The EEP-nuclease domain is boxed in red, and the mitochondrial
matrix-targeting peptide, mTP in blue. The matrix-targeting R2 motif, xRx#(S/x) and associated proteolytic-cleavage site (MPP) are indicated.
Vertical red lines specify the ﬁnal residue occurring in the natural protein. The initiator methionine in 20-PDEmTP600-His, not present in the native
protein, is highlighted in red. MPP, mitochondrial processing peptidase. (B) and (C)2 0-PDE615-His was transfected into the human HEK293 and
HeLa cell lines and protein expression allowed to proceed for 36h upon which cells were lysed and analyzed by immunoblotting using an antibody
against the His-tag (Rockland). Extracts from cells transfected with a construct encoding His-tagged OAS1-p42 or an empty-pcDNA3 vector (EV)
were used as positive and negative controls, respectively. Arrows indicate the full-length proteins whereas arrowheads specify N-terminally processed
forms. Of total protein, 20mg were loaded into each lane.
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for the identiﬁcation of mTPs as well as the most likely
N-terminal processing site conﬁrmed the putative mito-
chondrial localization with a probability of 95% with
the mTP predicted to constitute residues 1–16 of the
precursor (Figure 1A). Speciﬁcally, the N-terminus of
20-PDE contains an R2 motif, xRx#x(S/x), where the
arrow marks a proteolytic cleavage site, in this case
between Thr16 and Ala17. The presence of an R2 motif
in 20-PDE suggests that mitochondrial import proceeds
through a single cleavage event mediated by
a matrix-localized protease known as mitochondrial pro-
cessing peptidase, MPP (40). A characteristic feature of
mTPs is the presence of an amphipathic a-helix at the
N-terminus of the protein, which gets recognized by
membrane-bound import receptors in the mitochondrion
(41–43). To explore this possibility, GPMAW (44) was
used to predict the secondary structure in the
N-terminus of 20-PDE and a likely helical element was
found covering the initial 27 residues. Helical-wheel
analysis subsequently conﬁrmed that the amino acid
residues 7–24 would be consistent with an amphipathic
helix (Supplementary Figure S1).
Recombinantly expressed 20-PDE co-localizes with
mitochondria in an mTP-dependent fashion
Prompted by our bioinformatic discoveries, we next
wanted to experimentally conﬁrm the sub-cellular localiza-
tion of recombinant 20-PDE expressed in human cell lines.
Accordingly, the 20-PDE615-His construct was transfected
into HeLa cells, and the cells then analyzed by
immuno-ﬂuorescence microscopy in which mitochondria
were tracked by an organelle-speciﬁc stain (Mitotracker)
and the 20-PDE by an antibody toward the C-terminal
His-tag (Figure 2). The results clearly demonstrated
an almost complete co-localization of 20-PDE with
mitochondria under these conditions (Figure 2A–C).
His-tagged constructs encoding the known matrix-
localized heat shock protein 60, Hsp60 (45) and the
non-mitochondrial protein, OAS1-p42 (26)
were included as positive and negative controls,
respectively. To conﬁrm the signiﬁcance of the predicted
mTP, a variant lacking the expected signal peptide,
20-PDEmTP600-His (Figure 1A) was analyzed in
a similar way. This deletion variant showed a uniform
distribution throughout the cell, and furthermore was
found not to undergo post-translational processing to
the same extent as the full-length protein (Figure 2M).
Given the detection of an unspeciﬁc band in the
immunoblot in Figure 2M, it was important to ascertain
that cross-reactivity of the anti-His antibody did not
hamper the interpretation of the results described in
Figure 2A–L. This was conﬁrmed by conducting parallel
immuno-ﬂuorescence analyses on HeLa cells not trans-
fected, in addition to HeLa cells transfected with empty
vector pcDNA3, which did reveal no background staining
whatsoever (data not shown). Finally, these data deﬁning
20-PDE as a mitochondrial protein were afﬁrmed by
similar stainings done on 20-PDE-transfected HEK293
cells, which also showed a mitochondrial distribution of
the recombinant protein (Supplementary Figure S2).
In summary, 20-PDE appears to locate to the
mitochondria via an mTP-dependent mechanism. The
presence of at least three forms of 20-PDE when expressed
in HeLa cells suggests that a minimum of two processing
events are required to generate the mature, mitochondrial
form of 20-PDE, which is most likely represented by the
band of lowest molecular mass. The protein forms are
therefore denoted ‘precursor’, ‘intermediate’ and
‘mature’, by decreasing size.
Recombinant 20-PDE associates with the mitochondrial
sub-cellular fraction
To further analyze the complex processing and localiza-
tion pathway of 20-PDE, COS-7 cells transiently express-
ing the protein were separated into cytosolic and
mitochondrial fractions through differential centrifuga-
tion of cellular compartments. COS-7 cells were used in
this case for practical reasons and are generally assumed
to maintain a very homologous mitochondrial import and
processing function to the one found in human cells. In
this set-up, the full-length form encoded by 20-PDE615-His
and the construct lacking the mTP, 20-PDEmTP600-His,
were used. If the predicted mTP is indeed functional, the
truncated construct should be retained in the cytosol and
thus represent an appropriate control that would also
validate the purity of the mitochondrial fractions utilized
in these experiments. Following a 36h transient expres-
sion, His-tag immunoblotting on the total cell lysate and
a mitochondrial fraction clearly showed that the 20-
PDE615-His associates with mitochondria (Figure 3A).
In contrast, the 20-PDEmTP600-His is not targeted to
this organelle, but is exclusively found in the cytosolic
fraction (Figure 3B).
The identity of the 20-PDE band associated with
mitochondria was subsequently conﬁrmed by LC-MS/
MS of tryptic peptides prepared from all proteins con-
tained in the mitochondrial fractions. Accordingly,
within the 20-PDE615-His-speciﬁc sample, twelve peptides
were found matching 20-PDE (Supplementary Figure S3),
whereas none were identiﬁed in the mitochondrial fraction
from cells expressing 20-PDEmTP600-His. This is despite
a relatively low-estimated mitochondrial purity of  39%
based on the known localization of a wide range of other
identiﬁed proteins in the samples.
Endogenous 20-PDE associates with mitochondria
As protein expression by transient transfection could
potentially produce localization artifacts (46), we
decided to check if endogenous 20-PDE also localizes to
mitochondria using a similar MS-based approach. In this
case, human HEK293 cells were used due to a known high
expression level of endogenous 20-PDE (9). Mitochondrial
fractions were isolated as before and protein complexity
reduced by off-gel isoelectric focusing in the pH interval
3–10. In this set-up, a single mitochondrial preparation
was split into 12 individual samples distinguished by a
difference in pH (Supplementary Figure S4). Individual
samples were then treated with trypsin and analyzed by
Nucleic Acids Research,2011, Vol.39, No. 9 3759Figure 2. Cellular localization and post-translational processing of 20-PDE. (A–L) Immuno-ﬂuorescence microscopy images of HeLa cells transiently
transfected with constructs encoding 20-PDE615-His (A–C), the His-tagged Hsp60 (D–F) and OAS1-p42 controls (G–I) or the 20-PDEmTP600-His
deletion variant (J–L). After 36h, cells were probed with a His-tag speciﬁc antibody (Genscript) and stained with a FITC-conjugated second-
ary antibody (green). Mitchondria were visualized by treating live cells with Mitotracker (red). Scale bars; 10mm. (M) Immunoblotting on HeLa
protein extracts obtained 36h post-transfection with 20-PDE615-His and 20-PDEmTP600-His using a His-tag speciﬁc antibody (Genscript).
EV (empty-pcDNA3 vector) was used as a negative control. Arrows specify full-length 20-PDEs, whereas arrowheads mark the ‘intermediate’
(i) and ‘mature’ (m) processed forms of 20-PDE615-His. The asterisks indicate an unspeciﬁc band. Of total cell lysate, 20mg were loaded into each
lane. Note that due to practical reasons the results in Figure 2 were obtained with a different anti-His antibody as compared with the one utilized in
Figure 1.
3760 Nucleic Acids Research, 2011,Vol.39, No. 9LC-MS/MS. Two peptides speciﬁc for 20-PDE were
identiﬁed in the sample corresponding to a pI of approxi-
mately 6, consistent with the predicted pI of 6.11 for
full-length 20-PDE (Figure 3C). No 20-PDE-speciﬁc
peptides were found in the remaining samples. In total,
545 proteins were identiﬁed of which 225 represented
known mitochondrial proteins yielding a mitochondrial
purity of  41%. Note that in comparison to this
HEK293-speciﬁc enzymatic identiﬁcation, no peptides
derived from endogenous 20-PDE were identiﬁed in the
20-PDEmTP600-His mitochondrial preparation isolated
from COS-7 cells (described in the previous section).
Speciﬁcally, this disparity is likely to be the result of
either (1) the fact that the COS-7 sample was not off-gel
fractionated prior to LC-MS/MS analyses, or (2) simply
that the 20-PDE exhibits differential expression between
COS-7 and HEK293 cells.
20-PDE synthesized in vitro targets the mitochondrial
matrix
We next wanted to analyze the functional signiﬁcance of
the observed mitochondrial localization of 20-PDE by
identifying in which mitochondrial sub-compartment, i.e.
the outer membrane, the intermembrane space, the inner
membrane or the matrix, the protein is located. The
presence of the R2-sequence motif immediately suggests
that the protein would localize to the matrix, a destination
also supported by the sub-cellular prediction tool PSORT
(47). In addition, the trans-membrane prediction servers,
Phobius (48) and TopPred (49), did not locate any
membrane-associated elements, suggesting that 20-PDE
most likely is a soluble matrix protein.
To conﬁrm this hypothesis, the import of in vitro
synthesized,
35S-labeled 20-PDE615-His into mitochondria
was studied by incubation of the radioactive protein with
organelles obtained from HeLa cells. First, a control
time-course experiment was conducted whereby compo-
nents, i.e.
35S-labeled 20-PDE and mitochondria, were
mixed for 2–30min followed by gel-electrophoretic
analysis of the mitochondria pre-treated with proteinase
K, to reveal the efﬁciency of import (Figure 4A). In this
case, protein bands corresponding to the ‘precursor’,
‘intermediate’ and ‘mature’ forms of 20-PDE appeared
over time, showing that 20-PDE615-His is both imported
into mitochondria and at the same time undergoes
N-terminal processing like seen for the recombinantly
expressed protein. Furthermore, mitochondrial import
was found to be dependent on the membrane potential
across the inner membrane (c), which is consistent
with a localization to the matrix as only precursor
proteins destined for the inner membrane or matrix and
Figure 3. Human recombinant and endogenous 20-PDE targets the mitochondria of cells. (A) Immunoblotting on total cell lysate (T) and mito-
chondrial (M) fractions isolated upon transient expression of 20-PDE615-His for 36h in COS-7 cells using a His-tag speciﬁc antibody (Genscript).
(B) Immunoblotting as in (A) on 20-PDEmTP600-His-speciﬁc total cell lysate (T), mitchondrial (M) and cytoplasmic (C) samples obtained following
36 h of recombinant expression in COS-7 cells. In (A) and (B), arrows indicate 20-PDEs and asterisks mark unspeciﬁc bands. Twenty micrograms of
total cell lysate/cytoplasm and 5mg of mitochondrial protein were loaded into the respective lanes. (C) Intrinsic and mitochondrial-speciﬁc 20-PDE
peptides (red) in HEK293 cells as determined by LC-MS/MS of a tryptic digest prepared from all proteins in off-gel fraction 6 (emphasized in red in
Supplementary Figure S4). The detected y-ions (upper red boxes) and b-ions (lower red boxes) are shown, and the Arg(R)/Lys(K) residues
underscored in the protein sequence.
Nucleic Acids Research,2011, Vol.39, No. 9 3761in rare cases the intermembrane space, show c-depend-
ence during import (50).
We then wanted to clarify whether 20-PDE is part of the
soluble mitochondrial proteome represented by the matrix
and the intermembrane space, or alternatively, associates
with the inner mitochondrial membrane. To analyze this,
mitochondria were subjected to carbonate extraction after
import of the pre-protein, a technique that allows the sep-
aration of soluble and peripheral membrane proteins (S)
from integral membrane proteins (P) (51). Speciﬁcally, the
35S-labeled 20-PDE615-His was ﬁrstly incubated with the
mitochondria, this time for 30–60min, upon which the or-
ganelles pre-treated with proteinase K were carbonate
extracted, and the obtained fractions analyzed by gel elec-
trophoresis (Figure 4B). The results clearly indicated that
20-PDE is present in the soluble phase, i.e. either in the
intermembrane space or in the matrix.
Osmotic-induced swelling of mitochondria, whereby the
outer membrane is burst by lowering the external solute
concentration in a mitochondrial suspension while leaving
the inner membrane intact, can be used to distinguish
matrix proteins from proteins located in the
intermembrane space. In this technique, proteins within
or facing the intermembrane space become accessible to
an external protease, while matrix-located proteins remain
shielded. Accordingly, the subsequent isolation and
analysis of mitoplasts, the remaining particles comprising
the matrix enclosed by the inner membrane, allow for
discrimination between intermembrane space and matrix
proteins (52). Thus, using mitoplasts isolated from HeLa
mitochondria incubated with
35S-labeled 20-PDE615-His
for 30–60min, the sub-organellar localization of 20-PDE
could be deduced from gel analysis (Figure 4C). The
‘mature’ protein seemed unaffected by protease treatment
of the isolated mitoplasts [lanes marked M (mitoplasts)
with or without proteinase K treatment], suggesting that
20-PDE is a matrix protein. Although this does not
formally exclude that 20-PDE might be partly embedded
in the inner membrane with no parts protruding into the
intermembrane space, we have already shown that 20-PDE
forms part of the soluble mitochondrial phase and there-
fore conclude that 20-PDE is exclusively a mitochondrial
matrix protein.
20-PDE contains an EEP-type deadenylase domain and is
an active 30–50 exoribonuclease
Sequence analyses show that 20-PDE contains a so-called
EEP nuclease domain and hence shares similarity with the
cytoplasmic deadenylase families CCR4, Nocturnin and
ANGEL (Supplementary Figure S5). To characterize the
in vitro deadenylase activity of 20-PDE, the enzyme was
heterologously expressed and puriﬁed from E. coli.I n
doing so, the 20-PDE615-His and 20-PDEmTP600-
Figure 4. Mitochondrial import of radioactively labeled 20-PDE.
(A) Time-course experiment in which
35S-labeled 20-PDE615-His and
HeLa mitochondria were incubated for 2–30min followed by proteoly-
sis of non-imported proteins by treatment with proteinase K (+PK).
The sequestered
35S-labeled proteins were subsequently separated by
SDS–PAGE and visualized by phosphorimaging. c indicates
whether the mitochondrial membrane potential has been disrupted
( ) or not (+). The 10% input lane shows the result of in vitro tran-
scription/translation prior to import, and is relative to the total
quantity of
35S-labeled 20-PDE added into each import reaction
(100%). The arrow marks the position of 20-PDE615-His and arrow-
heads the location of the processed ‘intermediate’ (i) and ‘mature’ (m)
forms. (B). Carbonate extraction experiment in which import was per-
formed as in (A) for 30 and 60min, after which the mitochondria were
split by carbonate extraction into protein fractions containing the
integral membrane (P) and the soluble and peripheral membrane
parts (S). Speciﬁcally, whereas the T lanes provide the total quantity
and pattern of
35S-labeled protein after mitochondrial import but prior
to carbonate extraction, the 5% input lane presents the
35S-20-PDE615-
His-starting material prior to import, and is relative to the amount
utilized for each reaction (100%). (C) Osmotic-induced swelling
experiment in which mitoplasts (M) were obtained after import for 30
and 60min by osmotic-induced rupturing of the outer membrane
followed by proteolysis (where indicated). The asterisk marks that
this PK treatment constitutes the second treatment used to remove
accessible proteins upon stripping of the outer membrane. Shown are
also the control experiments where the membrane was kept intact (I).
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IPTG-inducible vector pTriEx-3 Neo, and the constructs
transformed into E. coli BL21(DE3). Then, prior to puri-
ﬁcation, IPTG-induced lysates expressing 20-PDE615-His
and 20-PDEmTP600-His, respectively, were tested for
their ability to degrade a 20–50-linked adenosine tetramer
core (ApApApA) to uncover a potential inﬂuence of
removing the mTP on enzyme activity. Speciﬁcally, the
lysates were found to degrade the 20–50 substrate with
similar efﬁciency, suggesting only a negligible impact (if
any) of the mTP on enzyme catalysis (Supplementary
Figure S6A). A lysate from cells transformed with an
empty-pTriEx-3 Neo vector was used as a control and
found to be inactive, in accordance with the fact that
20–50 RNA is not a natural substrate of any endogenous
E. coli enzymes. Immunoblotting was used to conﬁrm that
the two constructs expressed equally well in the
BL21(DE3) strain (Supplementary Figure S6B).
Consequently, based on an unaltered activity response
(compared to full-length 20-PDE) the 20-PDEmTP600-
His was chosen and puriﬁed to homogeneity
(Figure 5A), so as to simulate the mature mitochondrial
form as far as possible. During the expression and puriﬁ-
cation of 20-PDEmTP600-His, a stable degradation
product of  45kDa, referred to as 20-PDEN344-His,
was also isolated (Figure 5A). Both 20-PDEmTP600-His
and its truncated form were active in degradation of
20–50-linked substrates, but surprisingly, the truncated
protein appeared to be more active than 20-PDE
mTP600-His (Figure 5B). Mapping of the N-terminus
of 20-PDEN344-His by N-terminal sequencing
showed that it lacks the ﬁrst 256 residues compared to
20-PDEmTP600-His, and starts just upstream of
the core 20-PDE nuclease domain (Figure 5C). His-tag-
speciﬁc immunoblotting was likewise carried out con-
ﬁrming that in both 20-PDEmTP600-His and
20-PDEN344-His, the C-terminal His-tag is preserved
(Figure 5D).
To examine a possible role of 20-PDE in RNA
deadenylation, an in vitro degradation assay was set up
Figure 5. Puriﬁcation and validation of 20-PDE expressed in E. coli BL21(DE3). (A) Coomassie blue-stained gel after SDS–PAGE showing 20mgo f
puriﬁed 20-PDEmTP600-His and 20-PDEN344-His. Pop2p is a puriﬁed DEDD-type deadenylase from Schizosaccharomyces pombe used as a control
in (B) (20). Arrows specify the position of the indicated proteins. The M lane contains marker proteins of different molecular masses. (B)2 0–50
oligoadenylate degradation assay on the puriﬁed protein fractions from (A) using a 20–50 oligoadenylate tetramer, ApApApA, as substrate. The
deadenylase Pop2p is only active on 30–50-linked RNA and thus constitutes a negative control for 20–50 oligoadenylate degradation. Reactions were
performed in triplicate (mean/SEM) using 10mg of protein. (C) The 20-PDEN344-His truncation fragment and comparison to 20-PDEmTP600-His.
The ﬁve N-terminally sequenced residues of 20-PDEN344-His are shown (brown box). (D) Immunoblotting of the 20-PDE proteins from (A) using a
His-tag speciﬁc antibody (Genscript). A HEK293 total cell lysate expressing the 20-PDE615-His was employed as a positive control. Arrows denote
individual proteins and the arrowhead designates the singly processed form of 20-PDE615-His present in the HEK293 cell lysate. Of total protein,
10mg were loaded into each lane.
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ﬂuorescently labeled at the 50-end (Figure 6A).
RNA–Poly(A) substrate contained a 20-residue generic
unstructured RNA sequence followed by 10 adenosine
residues, while RNA Stemloop–Poly(A) contained an
8-bp strong helical structure followed by 10 adenosine
residues (20). The degradation of the substrates by
20-PDE was monitored in time-course experiments
carried out with either 20-PDEmTP600-His or
20-PDEN344-His using denaturing RNA gels
(Figure 6B and C, respectively). When 20-PDEmTP600-
His is incubated with RNA–Poly(A), the substrate is
removed in a slow and processive manner as seen by the
immediate build-up of small RNA fragments of 5–8nt
in size, without the appearance of intermediate length
RNAs. In contrast, the truncated protein,
20-PDEN344-His, initially only removes the poly(A) tail
from RNA–Poly(A), as seen by accumulation of com-
pletely deadenylated RNAs of 20nt after  10min
(Figure 6C). However, upon longer incubation the RNA
is degraded into small fragments of 4–11nt in size. 20-
PDEmTP600-His also degrades RNA–Poly(C) with rea-
sonable efﬁciency, demonstrating that 20-PDE is not
speciﬁc towards adenosine. The RNA–Poly(C) substrate
is likewise broken down by 20-PDEN344-His, although at
a much slower rate compared to the RNA–Poly(A) sub-
strate. These results suggest that 20-PDE confers some
degree of sequence preference towards adenosine, yet
Figure 6. The 30–50 exoribonuclease activity of human 20-PDE. (A) Sequence and predicted secondary structure of the RNA substrates used.
(B and C) Time-course degradation assays where puriﬁed 20-PDEmTP600-His (B) or 20-PDEN344-His (C) were incubated with deﬁned RNAs
(or DNA where speciﬁed) at 30 C for the indicated amount of minutes. The DNA–Poly(A) oligomer was similar to the RNA–Poly(A) but on the
DNA form. Ladder is a single-nucleotide ladder produced by limited alkaline hydrolysis of the substrates. Control lanes specify reactions in which
the RNAs (or DNA) were incubated for 120min at 30 C in the absence of enzyme.
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behavior is very similar to what is observed for the canon-
ical, cytoplasmic deadenylation enzymes (21). The 20-
PDEN344-His is not only faster than 20-PDEmTP600-
His, but appears to work in a more distributive
degradation mode, indicating an inherent functional sig-
niﬁcance of the N-terminal domain. RNAs containing a
strong secondary structure are also processed differently
by the two 20-PDE variants. While 20-PDEmTP600-His is
able to remove a strong secondary structure element down
to fragments of 4–5nt, the short variant, 20-PDEN344-
His, arrests 2nt before the stem. This suggests that the
N-terminus of 20-PDE contains elements that affect both
processivity and secondary structure unwinding of the
main exonuclease domain, most likely through an
RNA-binding domain. Unfortunately, bioinformatics did
not seem to support this notion, suggesting that if present,
this RNA-binding domain of 20-PDE may substantially
deviate from known RNA-binding regions. None of the
20-PDE variants were able to degrade a 20-deoxy substrate,
DNA–Poly(A), which is equivalent to RNA–Poly(A) but
on the DNA form. Furthermore, a BL21(DE3)-speciﬁc
protein fraction obtained from cells transformed with an
empty-pTriEx-3 Neo vector and puriﬁed according to the
same parameters as used for the 20-PDEs was inactive on
all RNA substrates (data not shown), strongly suggesting
that any contaminating traces of co-puriﬁed nuclease
activity is unlikely to contribute to the results seen in
Figure 6.
In conclusion, 20-PDE exhibits a general 30–50
riboexonucleolytic activity with a subtle preference for ad-
enosine like that observed for the canonical deadenylases.
20-PDE degrades 30–50-linked RNA with a preference for
adenosine
To address the apparent preference for adenosine further,
two 30–50-linked substrates (ApApApA, oligo-A and
CpCpCpC, oligo-C) were used to determine Michaelis–
Menten Km and Vmax values for 20-PDE. Both
20-PDEmTP600-His and 20-PDEN344-His were able to
degrade these short substrates completely down to a nu-
cleoside (adenosine or cytidine, respectively) and a
50-monophosphate nucleotide (AMP or CMP, respective-
ly) as judged by the chromatographic analyses of products
and determination of peak ratios ( 1:3) (Supplementary
Figure S7). For both 20-PDE forms, the Km on oligo-A is
approximately half of that measured for oligo-C with a
Vmax 1.4–1.7-fold higher for the oligo-A substrate
(Table 1). Thus, 20-PDE both has a higher afﬁnity and
activity for polyadenosine 30–50-linked RNA and therefore
closely matches the substrate speciﬁcity of cytosolic
deadenylases, deﬁned as 30–50 exoribonucleases that
prefer RNAs composed of adenosines (21).
A negative correlation exists between 20-PDE and
mitochondrial mRNA expression levels
To elucidate if 20-PDE is functionally involved in mito-
chondrial RNA turnover, either as an RNA deadenylase
or alternatively as a general RNA decay enzyme, HeLa
cells were transfected with a mix of four 20-PDE
siRNAs to downregulate the natural protein. 72 hours
post-transfection, total cellular RNA was then obtained
and qRT-PCR performed to evaluate an effect of 20-PDE
knockdown on chosen mitochondrial mRNAs, i.e. the
cytochrome c oxidase subunit I (CoxI), CoxII, CoxIII,
cytochrome b (CytB), NADH dehydrogenase subunit 4
(ND4) and ND6. Speciﬁcally, down-regulation of
20-PDE by  50% was found not to evoke any statistical
differences in mitochondrial mRNA expression levels,
compared with cells transfected with a GFP control
siRNA (Figure 7A). Despite hereof, the results seemed
to indicate a slight negative correlation between 20-PDE
and mitochondrial mRNAs, suggesting that 20-PDE may
ultimately act to destabilize these RNAs.
In order to test and validate this hypothesis, the
full-length 20-PDE615-His construct (in pcDNA3) was
transfected into HeLa cells and the protein overexpressed
for a period of 36h. Any given effect of 20-PDE on mito-
chondrial mRNAs was then evaluated by qRT-PCR as
above. Overexpression of the 20-PDE was found to
markedly destabilize mitochondrial mRNAs, compared
with cells transfected with control empty vector
pcDNA3 (Figure 7B). Speciﬁcally, three of the six
mRNAs were signiﬁcantly down-regulated, counting the
CoxI (28%#), CoxIII (34%#) and CytB (32%#) mRNAs.
The remaining mRNAs were only insigniﬁcantly reduced.
Collectively, these data therefore put forward the 20-PDE
as a likely catabolic player involved in mitochondrial
RNA turnover.
DISCUSSION
Human 20-PDE is thought to control the cellular level of
2-5As through speciﬁc degradation, thereby acting as a
negative regulator of the IFN-induced 2-5A system (9).
In this article, we present strong evidence that the
enzyme contains an N-terminal mitochondrial signal
peptide and possesses a sub-cellular localization to the
mitochondrial matrix. At present, two matrix-localized
peptidases, MPP and mitochondrial intermediate peptid-
ase (MIP), are known to participate in maturation of
mitochondrial proteins (53). A small number of
Table 1. Kinetic parameters
Substrate 20-PDEmTP600-His 20-PDEN344-His
Vmax(fmol
AMP*/s*/
pmol)
Km (mM) Vmax(fmol
AMP*/sec*/
pmol)
Km (mM)
oligo-A, ApApApA 11.4±0.5 74±13 18.7±0.8 72±14
oligo-C, CpCpCpC 8.2±0.4 126±26 10.8±0.6 142±31
20-PDEmTP600-His and 20-PDEN344-His were incubated with
varying substrate concentrations of oligo-A, ApApApA or oligo-C,
CpCpCpC, substrates at 37 C for 20min followed by determination
of the Michaelis–Menten Km and Vmax values based on the MonoQ
elution proﬁles obtained as in Supplementary Figure S7. The Km and
Vmax parameters were derived by non-linear regression using the
GraphPad Prism Software. All reactions were performed in triplicate
and is shown as mean±SEM.
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cleavage by MPP and MIP (54). The appearance of an
intermediate-sized 20-PDE band in HeLa cells could
suggest that 20-PDE undergoes such two-step maturation.
Sequential maturation of precursor proteins occur
through recognition of the R10 motif, xRx|(F/L/I)xx(S/
T/G)xxxx#, where the vertical line and arrow indicate
the cleavage sites for MPP and MIP, respectively (40).
Thus MPP leaves an intermediate with an N-terminal
octapeptide extension which is subsequently removed by
MIP (54,55). However, two ﬁndings indicate that the ﬁnal
step in maturation of 20-PDE is not catalyzed by MIP.
First, an R2 motif, speciﬁc for MPP and not MIP rather
than the R10 motif was found in 20-PDE. Second, the size
difference between the ‘intermediate’ and ‘mature’ forms
of  7kDa is not compatible with the removal of an
octapeptide ( 1kDa). It is therefore possible that the
second cleavage event in maturation of 20-PDE results
from the activity of a yet unidentiﬁed peptidase (56,57).
Three similar forms of 20-PDE have previously been
observed in human cells, but in this case the phenomenon
was ascribed to the usage of alternate translation start
codons triggered by ‘weak’ Kozak signals (9).
Speciﬁcally, the Kozak consensus for initiation of transla-
tion in vertebrates is: (G/A)CCATGG (58). In this sense, a
‘strong’ Kozak signal contains a purine (either G or A) at
position  3 and a G nucleotide at position+4 relative to
the adenine of the ATG initiator positioned at+1 (there is
no number 0 position). Further, an ‘adequate’ consensus
contains only one of these sites, while a ‘weak’ consensus
has neither. Indeed the genome sequence around the ATG
start codon in 20-PDE, TTCATGT, represents a ‘weak’
Kozak signal, thus rendering this ATG triplet prone to
ribosome skipping. However, the presence of a ‘strong’
Kozak sequence at the second ATG triplet,
GCGATGG, encoding Met35 makes ribosome skipping
at this position highly unlikely. Furthermore, even
though an ATG codon at Met35 is in accordance with
the observed size difference between the ‘precursor’ and
the ‘intermediate’ form (2–4kDa), the next ATG triplet
found at Met63 is not compatible with the  7kDa that
separates the ‘intermediate’ and ‘mature’ band.
Consequently, we argue that the appearance of three
20-PDE forms results from protein processing, and not
the usage of alternate translation start codons.
The observed localization of 20-PDE to the mitochon-
drial matrix immediately seemed puzzling in light of its
known role within the predominant nuclear- and
cytosolic-based 2-5A system, suggesting an additional
more mitochondria-speciﬁc activity of this enzyme
(24–29). Based on both a functional and structural simi-
larity of 20-PDE to RNA deadenylases, this might very
well be in mitochondrial RNA turnover (9,15–17). The
current ﬁnding of an inverse relationship between
20-PDE and mitochondrial mRNA expression levels,
supports this hypothesis and demonstrates that 20-PDE
may act to degrade these RNAs. Whether this is the
result of a principal role in RNA deadenylation or in
general RNA decay, however, remains to be elucidated.
In human mitochondria, both RNA deadenylation and
general RNA decay remains an unresolved issue (59,60).
Previously, mammalian polynucleotide phosphorylase
(PNPase) was suggested to be responsible for RNA
deadenylation in mitochondria (61). However, the discov-
ery that PNPase is localized to the mitochondrial
intermembrane space and that knockdown does not
affect RNA levels inside the matrix compartment,
recently questioned this hypothesis (59). The data
reported here deﬁning 20-PDE as a general 30–50
exoribonuclease with some preference for adenosine, is
compatible to what is seen for most deadenylases, and
therefore consistent with a role in RNA deadenylation
(21,22,30–33). For instance, in Saccharomyces cerevisiae,
the bulk of cytoplasmic deadenylation is maintained by
the Ccr4 subunit of the Ccr4-Not complex (62), a large
complex composed of seven core proteins including two
deadenylases (Ccr4 and Pop2p) (63,64). In vitro, both
Ccr4 and Pop2p nucleases show a preference for
Figure 7. 20-PDE destabilizes mitochondrial mRNAs. qRT-PCR analyses of mitochondrial mRNAs following (A) siRNA knockdown, or
(B) plasmid-mediated overexpression, of 20-PDE in HeLa cells. In (A), cells were transfected with a pool of 20-PDE siRNAs and incubated for
72h prior to performing qRT-PCR analysis. Cells transfected with a GFP-speciﬁc siRNA were used as a negative control. In (B), 20-PDE615-His
transfectants were analyzed by qRT-PCR 36h post-transfection. Cells treated with empty vector (EV) pcDNA3 were employed as a negative control.
(A and B) Relative expression was calculated by normalization to RPL13A expression levels followed by gene-speciﬁc normalization, setting the
controls to 1. Data are averages of triplicate qRT-PCR reactions, and the error bars denote standard deviations. Both experiments were repeated
three times, each time with similar results. Asterisks denote those mRNAs exhibiting differential expression.
3766 Nucleic Acids Research, 2011,Vol.39, No. 9poly(A)-containing substrates, yet are able to degrade
other sequences as well (21,22,33). Like many
RNA-degrading enzymes, it is possible that 20-PDE asso-
ciates with other proteins in vivo inside the mitochondria
that more precisely deﬁnes its substrates, but this is at
present pure speculation.
In contrast to the exclusive stabilizing effect imposed by
poly(A) tails added to cytoplasmic mRNAs, the poly(A)
tail of human mitochondrial mRNAs is known to provide
both stability and instability to the RNA, the outcome
being dictated by the exact site of poly(A) addition
(61,65,66). Speciﬁcally, human mitochondrial mRNAs
can be poly(A) modiﬁed by (i) internal polyadenylation
subsequent to endonucleolytic RNA cleavage, or (ii) by
‘normal’ polyadenylation taking place at the mature
30 termini. In the former case, transcripts are marked to
be degraded, whereas in the latter, they are stabilized.
Suppose 20-PDE carries out mitochondrial RNA
deadenylation, which poly(A) tails, i.e. the internal
added tails or the mature 30 terminal tails, then constitute
the main target for 20-PDE. Though this of course remains
speculative, the capacity of 20-PDE to destabilize and
down-regulate mitochondrial mRNAs would be consistent
with a role in processing of the mature 30-terminal tails,
normally known to stabilize their RNA targets. On the
contrary, 20-PDE could also, or exclusively, be processing
the internal added tails, and by this means cause RNA
destabilization.
As stated, the 20-PDE needs not be delimited to a
molecular role in RNA deadenylation, but might alterna-
tively be generally involved in the degradation of entire
mitochondrial RNAs. For instance, in yeast where mito-
chondrial RNAs, remarkably, are not polyadenylated
(67), RNA decay is maintained by a large enzyme
machinery termed the ‘mitochondrial degradosome’ con-
taining RNA helicase (Suv3p) and 30–50 exoribonuclease
(Dss1p) activities (68,69). Based on similar properties
recognized here for the 20-PDE, i.e. a general 30–50
exoribonuclease activity combined with the ability to
unwind secondary structures, human mitochondrial
RNAs may indeed be processed by this enzyme.
As for its role in the 2-5A system, we speculate that the
2-5A core molecules and not their 50-phosphorylated
variants, are the natural substrates for 20-PDE. First,
viral infection prompts the accumulation of 2-5A core
molecules—not 2-5As—to levels of micromolar magni-
tudes suggesting that a 50-phosphatase initiates 2-5A
catabolism (11,70). Second, the dephosphorylated and
hence less charged 2-5A core molecules are more likely
to passively traverse the hydrophobic barrier formed by
the mitochondrial inner membrane (71,72). Alternatively,
if not translocated by diffusion, a membrane-positioned
2-5A core solute-carrier, akin to the ADP/ATP antiporter,
may exist and transport 2-5A core molecules into the
mitochondrial matrix. Finally, the micromolar Km values
estimated for 20-PDE on the phosphorylated 20–50 sub-
strates (15) are much higher compared to the nanomolar
2-5A levels sufﬁcient for activating RNase L (12),
indicating that a 50-phosphatase indeed performs the
initial cleavage in the overall 2-5A catabolism.
Based on these ﬁndings, we present a model (Figure 8)
that besides accounting for the complete 2-5A catabolism
includes a mechanism of how the cellular 2-5A level is
regulated following viral exposure. In this scheme,
RNase L and a 50-phosphatase are both activated by
2-5A levels in the nanomolar range to (i) relieve cells of
viral infection and (ii) to protect against the cytotoxic
events resulting from build-up of 2-5As. Accordingly,
Figure 8. The 2-5A system—regulation and catabolism. Normally, the cellular concentration of 2-5As is kept below the nanomolar range (10,73),
maintaining the pathway in an inactive state. Then, when increased to nanomolar levels by the IFN-induced 20–50-OASs, 2-5As activate RNase L and
a5 0-phosphatase, which results in the degradation of viral RNA and in the conversion of the cytotoxic 2-5As into dephosphorylated 2-5A core
molecules. Accumulation of 2-5A core molecules to micromolar concentrations subsequently result in transport across the mitochondrial inner
membrane and into the matrix by a yet unidentiﬁed mechanism. Within the mitochondrial matrix, 20-PDE completes 2-5A catabolism by degradation
of the incoming 2-5A core molecules. The 2-5A catabolic pathway is speciﬁed by red arrows, and the possible involvement of yet to be discovered
non-mitochondrial 20-PDEs (20-PDE?) is illustrated by a red dotted arrow.
Nucleic Acids Research,2011, Vol.39, No. 9 3767when raised to nanomolar levels, 2-5As not only stimulate
RNase L, but are simultaneously converted into the less
cell-toxic 2-5A core molecules. The resulting ‘cores’ then
concentrate to micromolar levels and are transported
across the mitochondrial inner membrane into the
matrix where they function as substrates for 20-PDE.
Notice that despite here having deﬁned 20-PDE as a mito-
chondrial protein, the possible occurrence of any
non-mitochondrial forms hereof, e.g. arising by alterna-
tive splicing creating isoforms devoid of an N-terminal
mTP, can at present not be excluded. Speciﬁcally, as the
properties of such variants would be expected to be very
similar to that of the mitochondrial protein, the 2-5A core
molecules should also constitute their primary substrates.
The hypothetical presence of non-mitochondrial 20-PDEs
were included in Figure 8, to illustrate yet a factor poten-
tially involved in 2-5A catabolism.
In conclusion, we have shown that 20-PDE, a down-
regulator of the cytoplasmic 2-5A system, comprises a
matrix-localized mitochondrial protein very likely also to
be involved in organellar RNA turnover. Whether this
role is in general RNA decay or in RNA deadenylation
remains to be determined.
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